FDA Drug Shortages (New and Updated) - October 12, 2021

You are subscribed to FDA Drug Shortages. This information has recently been updated, and is now available. FDA Drug Shortages Atropine Sulfate Injection (Updated - Currently in Shortage) Bumetanide Injection (Updated - Currently in Shortage) Ceftolozane and Tazobactam (Zerbaxa) Injection (Updated - Currently in Shortage) Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage) Diltiazem Hydrochloride Injection (Updated - Currently in Shortage) Fentanyl Citrate (Sublimaze) Injection (New - Currently in Shortage) Echothiophate Iodide (Phospholine Iodide) Ophthalmic Solution (Updated - Currently in Shortage) Enalaprilat Injection (Updated - Currently in Shortage) Famotidine Injection (Updated - Currently in Shortage) Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage) Floxuridine for Injection (Updated - Currently in Shortage) Ketamine Injection (Updated - Currently in Shortage) Leucovorin Calcium Lyophilized Powder for Injection (Updated - Currently in Shortage) Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage) Morphine Sulfate Injection (Updated - Currently in Shortage) Montelukast Sodium Chewable Tablet (New - Discontinuation) Propofol Injectable Emulsion (Updated - Currently in Shortage) Valproate Sodium Injection (Updated - Currently in Shortage) Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA